Clinical Trial Update: Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temozolomide with thalidomide in patients with metastatic, locally advanced, or unresectable leiomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN